Clinical Trial Update: Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies

View source ↗

Summary

An ongoing clinical trial is investigating cancer and immune cell metabolism in patients with hematologic malignancies and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Hematologic Malignancy | Status: RECRUITING